Related Experiment Video
Updated: Dec 19, 2025
06:46
Quantitative Micro-CT Analysis of Aortopathy in a Mouse Model of β-aminopropionitrile-induced Aortic Aneurysm and Dissection
Published on: July 16, 2018
9.9K
Circulating microRNAs vs. aortic diameter in bicuspid aortic valve aortopathy
Shiho Naito1, Johannes Petersen1, Tatiana Sequeira-Gross1
1Department of Cardiovascular Surgery, University Heart and Vascular Center Hamburg.
Asian Cardiovascular & Thoracic Annals
|June 6, 2020
Summary
Novel risk prediction tools are needed for bicuspid aortic valve aortopathy. Current diameter-based methods are limited, highlighting the need for new diagnostic approaches like microRNA biomarkers to predict aortic disease progression.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Biomarkers
Background:
- Bicuspid aortic valve aortopathy (BAV-aortopathy) affects the proximal aorta.
- Current diameter-based risk stratification has limitations for predicting adverse aortic events.
- There is a clinical need for improved diagnostic tools and treatment guidelines.
Purpose of the Study:
- To summarize current evidence on novel diagnostic developments for BAV-aortopathy risk stratification.
- To highlight the potential of circulating microRNAs as predictive biomarkers.
Main Methods:
- Review of current scientific literature on BAV-aortopathy.
- Analysis of emerging diagnostic tools and biomarkers.
- Focus on circulating microRNAs for disease progression prediction.
Main Results:
- Diameter-based risk stratification for BAV-aortopathy is insufficient.
- Circulating microRNAs show promise as biomarkers for aortic disease progression.
- Novel diagnostic tools are under investigation to improve patient management.
Conclusions:
- Improved risk stratification is crucial for BAV-aortopathy management.
- MicroRNA biomarkers offer a potential avenue for predicting disease progression.
- Further research and guideline adjustments are necessary for optimal patient care.
Related Concept Videos
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
278
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
278
01:15Aortic Regurgitation I: Introduction
317
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
317
01:22Mitral Stenosis I: Introduction
254
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
254
01:25Aortic Regurgitation III: Medical Management
261
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
261